These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Difficulties in eliminating measles and controlling rubella and mumps: a cross-sectional study of a first measles and rubella vaccination and a second measles, mumps, and rubella vaccination. Wang Z, Yan R, He H, Li Q, Chen G, Yang S, Chen E. PLoS One; 2014; 9(2):e89361. PubMed ID: 24586717 [Abstract] [Full Text] [Related]
25. Antibody persistence in young adults 1 year after MMR immunization by aerosol or by subcutaneous route. Díaz-Ortega JL, Bennett JV, Castañeda D, Martinez D, de Castro JF. Vaccine; 2010 Oct 18; 28(44):7228-32. PubMed ID: 20800111 [Abstract] [Full Text] [Related]
27. Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age. Ceyhan M, Kanra G, Erdem G, Kanra B. Vaccine; 2001 Aug 14; 19(31):4473-8. PubMed ID: 11483273 [Abstract] [Full Text] [Related]
28. Kinetics of antibody and memory B cell responses after MMR immunization in children and young adults. Kakoulidou M, Ingelman-Sundberg H, Johansson E, Cagigi A, Farouk SE, Nilsson A, Johansen K. Vaccine; 2013 Jan 11; 31(4):711-7. PubMed ID: 23174196 [Abstract] [Full Text] [Related]
30. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella. Wellington K, Goa KL. Drugs; 2003 Jan 11; 63(19):2107-26. PubMed ID: 12962524 [Abstract] [Full Text] [Related]
31. Lack of association between measles-mumps-rubella vaccination and autism in children: a case-control study. Mrozek-Budzyn D, Kiełtyka A, Majewska R. Pediatr Infect Dis J; 2010 May 11; 29(5):397-400. PubMed ID: 19952979 [Abstract] [Full Text] [Related]
33. [Experience with preventive measles, mumps and rubella vaccination in unified Germany]. Gerike E, Tischer A. Gesundheitswesen; 1993 Jan 11; 55(1):38-9. PubMed ID: 8435543 [Abstract] [Full Text] [Related]
36. Immunogenicity and efficacy of Hoshino strain of mumps vaccine in Iran; two years study. Avijgan M, Hafizi M, Moghni M, Kheiri S, Esteghamati A, Sarikhani S. East Afr J Public Health; 2011 Jun 11; 8(2):88-91. PubMed ID: 22066292 [Abstract] [Full Text] [Related]
38. The Immunogenicity and Safety Profile for KM-248, a Combined Measles, Mumps, and Rubella Vaccine, and Its Noninferiority to the Measles Vaccine in Healthy Japanese Children: a Phase 3 Randomized Multicenter Single-Blind Clinical Trial. Platt H, Tochihara S, Oda Y, Ueda K. Jpn J Infect Dis; 2021 Sep 22; 74(5):429-436. PubMed ID: 33518626 [Abstract] [Full Text] [Related]
39. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Zignol M, Peracchi M, Tridello G, Pillon M, Fregonese F, D'Elia R, Zanesco L, Cesaro S. Cancer; 2004 Aug 01; 101(3):635-41. PubMed ID: 15274078 [Abstract] [Full Text] [Related]
40. Serosurvey of measles, mumps and rubella antibodies in Saudi children. Al-Mazrou YY, Khalil MK, Tischer A, Al-Jeffri MH, Al-Ghamdi YS, Bakhsh MM, Mishkas AA, Elgizouli SA. Saudi Med J; 2005 Oct 01; 26(10):1551-4. PubMed ID: 16228054 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]